NMR and molecular modeling characterization of HIV-1 protease inhibitors: Difunctional enols of N-protected phenylalanine

Tetrahedron

Volumn 53, Issue 12, 1997, Pages 4231-4238

  Boulanger, Yvan ^a   Larocque, Alain ^a   Khiat, Abdesslem ^a   Deschamps, François ^b   Sauvé, Gilles ^b  

^a INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; PROTEINASE INHIBITOR;

ARTICLE; CALCULATION; CHIRALITY; DRUG DESIGN; DRUG STRUCTURE; ENZYME BINDING; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; THERMODYNAMICS;

EID: 0031585065     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(97)00150-6     Document Type: Article

References (9)

1. 1. Huff, J.R. J. Med. Chem. 1991, 34, 2305-2314.
2. 2. Wlodawer, A.; Erickson, J.W. Annu. Rev. Biochem. 1993, 62, 543-585.
3. 3. Vaillancourt, M.; Vanasse, B.; Cohen, E.; Sauvé, G. Bioorg. Med. Chem. Lett. 1993, 3, 1169-1174.
4. 4. Vaillancourt, M.; Vanasse, B.; Le Berre, N.; Cohen, E.; Sauvé, G. Bioorg. Med. Chem. 1994, 2, 343-355.
5. 5 Vaillancourt, M.; Cohen, E.; Sauvé, G. J. Enzyme Inhib. 1995, 9, 217-233.
6. 6. Dreyer, G.B.; Lambert, D.M.; Meek, T.D.; Carr, T.J.; Tomaszek, Jr., T.A.; Fernandez, A.V.; Bartus, H.; Cacciavillani, E.; Hassell, A.M.; Minnich, M.; Petteway, Jr., S.R.; Metcalf, B.W.; Lewis, M. Biochemistry 1992, 31, 6646-6659.
7. 7. Ludvigsen, S.; Andersen, K.V.; Poulsen, F.M. J. Mol. Biol. 1991, 217, 731-736.
8. 8. DeMarco, A.; Llinas, M.; Wüthrich, K. Biopolymers 1978, 17, 637-650.
9. 9. Appelt, K. Persp. Drug Disc. Design 1993, 1, 23-48.